Stock Taper 
ROCK SPRINGS CAPITAL MANAGEMENT LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Aclaris Therapeutics, Inc. | ACRS | 4.33M | $22.91M |
 Evolent Health, Inc. | EVH | 2.5M | $13.55M |
 Ardelyx, Inc. | ARDX | 2.24M | $11.43M |
 Travere Therapeutics, Inc. | TVTX | 2.18M | $123.79M |
 MiniMed Group, Inc. Common Stock | MMED | 1.52M | $22.72M |
 Erasca, Inc. | ERAS | 1.4M | $25.69M |
 Revolution Medicines, Inc. | RVMD | 1.11M | $206.98M |
 Ultragenyx Pharmaceutical Inc. | RARE | 967.86K | $32.32M |
 Dyne Therapeutics, Inc. | DYN | 942.15K | $20.93M |
 Mirum Pharmaceuticals, Inc. | MIRM | 798.14K | $93.44M |
 Omeros Corporation | OMER | 718.5K | $6.83M |
 Scholar Rock Holding Corporation | SRRK | 715.45K | $39.35M |
 Summit Therapeutics Inc. | SMMT | 715K | $10.42M |
 Celldex Therapeutics, Inc. | CLDX | 699.15K | $26.02M |
 Phreesia, Inc. | PHR | 696.9K | $7.17M |
 Rhythm Pharmaceuticals, Inc. | RYTM | 692.6K | $76.9M |
 Xenon Pharmaceuticals Inc. | XENE | 683.91K | $41.28M |
 Avalyn Pharma Inc. Common Stock | AVLN | 662.92K | $21.82M |
 Pharvaris N.V. | PHVS | 648.33K | $22.42M |
 NewAmsterdam Pharma Company N.V. | NAMS | 582.74K | $19.75M |